journal article·2019-12-04Open access

The therapeutic effect of secretome from human umbilical cord-derived mesenchymal stem cells in age-related osteoporosis

Min Liang, Wanguo Liu, Zhibin Peng, Shihong Lv, Ying Guan, Gang An, Yubo Zhang, Tianwen Huang, Yansong Wang

Abstract

Senile osteoporosis is closely related to the loss of function of stem cells. In this study, we tried to investigate the potential of secretome from human umbilical cord-derived mesenchymal stem cells (hUCMSCs) in recovering stem cell ability from senescence and then delaying bone loss. We first harvested bone marrow-derived mesenchymal stem cells (BMSCs) from young and old rats and then compared their cellular characteristics such as cell growth, anti-senescence and differentiation. The results showed that these abilities were negatively affected by animal aging. Subsequently, aged BMSCs were exposed to secretome from hUCMSCs, and we found that this loss of cell potential can be modified by secretome treatment. Thereafter, the secretome was loaded into silk fibroin-based hydrogels and used for an in vivo animal study. The results showed that compared to the old untreated group, the bone formation capacity of aged rats was improved by local treatment of secretome-loaded silk fibroin hydrogels. In conclusion, these findings demonstrated that secretome from hUCMSCs has the capacity to recover stem cell potential and delay local bone loss in age-related osteoporosis, which could potentially be applied in osteoporosis therapy in the future.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Periodontal Regeneration and Treatments · Osteoarthritis Treatment and Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Spine Surgery, the First Affiliated Hospital of Harbin Medical University

Department of Orthopaedic Surgery, China-Japan Union Hospital, Jilin University

Department of Gastroenterol, the Second Affiliated Hospital of Mudanjiang Medical University

Funding

Key Laboratory of Myocardial Ischemia · Ministry of Education, Harbin Medical University

References (42)

Show source-provided references
1. Hennemann A. Osteoporosis: prevention, diagnosis and therapy. Med Monatsschr Pharm. 2002;25:164–167.
2. 10.1172/JCI2707110.1172/JCI27071 ↗
3. 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H ↗
4. 10.1007/BF0162335210.1007/BF01623352 ↗
5. 10.1056/NEJMra05307710.1056/NEJMra053077 ↗
6. 10.1016/S2213-8587(17)30188-210.1016/S2213-8587(17)30188-2 ↗
7. 10.1096/fj.10-16149710.1096/fj.10-161497 ↗
8. 10.1016/j.biomaterials.2014.05.01610.1016/j.biomaterials.2014.05.016 ↗
9. 10.1038/nature0326010.1038/nature03260 ↗
10. 10.1016/j.addr.2014.10.00710.1016/j.addr.2014.10.007 ↗
11. An G, Zhang WB, Ma DK, et al. Influence of VEGF/BMP-2 on the proliferation and osteogenetic differentiation of rat bone mesenchymal stem cells on PLGA/gelatin composite scaffold. Europ Rev Med Pharmacol Sci. 2017;21:2316.
12. 10.1155/2013/47493110.1155/2013/474931 ↗
13. 10.1002/adhm.20150039210.1002/adhm.201500392 ↗
14. 10.1016/j.biomaterials.2007.11.00310.1016/j.biomaterials.2007.11.003 ↗
15. 10.1186/s12967-014-0260-810.1186/s12967-014-0260-8 ↗
16. 10.5772/6335710.5772/63357 ↗
17. 10.1089/ars.2014.594110.1089/ars.2014.5941 ↗
18. 10.1089/scd.2014.048410.1089/scd.2014.0484 ↗
19. 10.1007/s11064-008-9812-810.1007/s11064-008-9812-8 ↗
20. 10.1111/j.1474-9728.2004.00127.x10.1111/j.1474-9728.2004.00127.x ↗
21. 10.1359/jbmr.08030410.1359/jbmr.080304 ↗
22. 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C ↗
23. 10.1016/j.biomaterials.2014.08.03410.1016/j.biomaterials.2014.08.034 ↗
24. 10.1371/journal.pone.012059310.1371/journal.pone.0120593 ↗
25. 10.1016/j.biomaterials.2011.05.08010.1016/j.biomaterials.2011.05.080 ↗
26. 10.18632/oncotarget.253010.18632/oncotarget.2530 ↗
27. Zhu CT, Li T, Zhang P, et al. Beneficial effects of low-level laser irradiation on senile osteoporosis in rats. Eur Rev Med Pharmacol Sci. 2007;21:5230–5238.
28. 10.1016/j.exger.2007.08.00810.1016/j.exger.2007.08.008 ↗
29. 10.1111/acel.1279410.1111/acel.12794 ↗
30. 10.1016/j.archger.2013.10.00510.1016/j.archger.2013.10.005 ↗
31. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1117>3.0.CO;2-I10.1002/1097-0215(200002)9999:9999<::AID-IJC1117>3.0.CO;2-I ↗
32. 10.1007/s11033-010-0665-210.1007/s11033-010-0665-2 ↗
33. 10.1016/j.exger.2006.10.01110.1016/j.exger.2006.10.011 ↗
34. 10.1016/j.molmed.2009.08.00410.1016/j.molmed.2009.08.004 ↗
35. 10.1002/term.242210.1002/term.2422 ↗
36. 10.4161/cc.9.18.1304610.4161/cc.9.18.13046 ↗
37. 10.1007/s00223-001-2059-x10.1007/s00223-001-2059-x ↗
38. 10.1002/term.198110.1002/term.1981 ↗
39. 10.1016/j.msec.2016.04.04310.1016/j.msec.2016.04.043 ↗
40. Bai L, Li D, Li J, et al. Bioactive molecules derived from umbilical cord mesenchymal stem cells. Acta Histochemica. 2016;118:761–769.
41. 10.2217/rme.12.110.2217/rme.12.1 ↗
42. 10.1091/mbc.9.7.190310.1091/mbc.9.7.1903 ↗